BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9662912)

  • 1. [Function of maternal immune-system and the embryonic sensitivity to teratogens].
    Fein A; Torchinsky A; Toder V
    Harefuah; 1998 Feb; 134(3):198-200. PubMed ID: 9662912
    [No Abstract]   [Full Text] [Related]  

  • 2. MHC-associated immunopotentiation affects the embryo response to teratogens.
    Torchinsky A; Fein A; Carp HJ; Toder V
    Clin Exp Immunol; 1994 Dec; 98(3):513-9. PubMed ID: 7994915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Environmental hazards for the human embryo and fetus].
    Dodinval P
    FNIB; 1978 Feb; 56(1):15-21. PubMed ID: 246409
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drugs in prenatal life].
    Halikowski B
    Pediatr Pol; 1978 Feb; 53(2):233-8. PubMed ID: 345206
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs and pregnancy.
    Yaffe SJ
    Clin Toxicol; 1978; 13(4):523-33. PubMed ID: 747910
    [No Abstract]   [Full Text] [Related]  

  • 7. [Embryotoxic, teratogenic and cancerogenic effects of N-nitrosomethyl urea in rats].
    Aleksandrov VA
    Vopr Onkol; 1974; 20(12):76-82. PubMed ID: 4446474
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trophoblastic interferons and embryonal immune tolerance].
    Martal J; De La Llosa-Hermier MP; Chêne N; Huynh L; Millet S; L'Haridon R; Assal A; Roignant N; Chaouat G
    Contracept Fertil Sex; 1995 Sep; 23(9):562-72. PubMed ID: 7496430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cadmium on placental structure and its relation to fetal malformations in the mouse.
    Padmanabhan R
    Z Mikrosk Anat Forsch; 1986; 100(3):419-27. PubMed ID: 3765785
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental improvement and reduced distal limb defects by maternal interferon-gamma injection in methylnitrosourea-exposed mice.
    Laudermilch CL; Holladay SD; Sponenberg DP; Saunders GK; Ward DL; Prater MR
    Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):597-604. PubMed ID: 16080182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental methods for the detection of teratogens].
    Tuchmann-Duplessis H
    Biol Med (1971); 1974 Nov; 3(2):91-147. PubMed ID: 4620255
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoteratology: I. MHC involvement in the embryo response to teratogens in mice.
    Torchinsky A; Fein A; Toder V
    Am J Reprod Immunol; 1995 Nov; 34(5):288-98. PubMed ID: 8595128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Teratogens].
    Julián M
    Rev Chil Pediatr; 1988; 59 Suppl 3():9-12. PubMed ID: 3271376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drugs and the fetus].
    Rise A
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):41-2. PubMed ID: 1257952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drugs and fetus].
    Rise A
    Ugeskr Laeger; 1976 Aug; 138(36):2171-2. PubMed ID: 968969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Editorial: Drugs and abnormalities. Background and consequences of warnings].
    Naess K
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):47-8. PubMed ID: 1257958
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemical mechanisms of mammalian teratogenesis].
    Repin VS
    Usp Sovrem Biol; 1978; 85(3):463-78. PubMed ID: 356453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.